000 04527nam a22004215i 4500
999 _c368072
_d368072
_x1
001 368072
003 ES-MaUEC
005 20230102121704.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 220214s2022 sz | s |||| 0|eng d
020 _a9783030727024
024 7 _a10.1007/978-3-030-72702-4
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC270.8
_b2022 EB
245 1 0 _aColon Cancer Diagnosis and Therapy Vol. 3
_cedited by Dhananjay Shukla, Naveen Kumar Vishvakarma, Ganji Purnachandra Nagaraju.
250 _aFirst edition 2022
264 1 _aCham
_bSpringer International Publishing
_c2022
300 _a1 recurso en línea (XVI, 460 páginas)
_b38 ilustraciones, 32 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aarchivo de texto
_bPDF
505 0 _aChapter 1. Role of chemokines in colorectal cancer -- Chapter 2. Extracellular vesicles in colorectal cancer growth, metastasis, diagnosis and therapy -- Chapter 3. Epigenetic regulation of colorectal cancer (CRC) -- Chapter 4. Mechanistic exploration and therapeutic management of colon cancer metastasis -- Chapter 5. Chemoresistance in colon malignancies -- Chapter 6. Targeting pathogenic inflammation for therapeutic intervention against colon cancer -- Chapter 7. Role of tumor associated macrophages in colon cancer progression and its therapeutic targeting -- Chapter 8. Therapeutic intervention of signaling pathways in colorectal cancer -- Chapter 9. Advances in chemoradiotherapy for treatment of colon cancer -- Chapter 10. Cytotoxic and chemopreventive activity of polyphenols and their derivatives in colon cancer -- Chapter 11. Prevention and management of colon cancer by nutritional intervention -- Chapter 12. Development of RNA based medicine for colorectal cancer -- Chapter 13. Role of food additives and intestinal microflora in colorectal cancer -- Chapter 14. Probiotics in colon cancer -- Chapter 15. Bacterial cancer therapy -- Chapter 16. Antineoplastic effects of curcumin against colorectal cancer -- Chapter 17. Cyanobacterial secondary metabolite -- Chapter 18. Clinical significance of genetic variants in colon cancer.
520 _aColorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis. This book is the third of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutics, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.
988 _aSpringer_BiomedLife_2022
650 7 _2embne
_9174085
_aCáncer
_xTratamiento
700 _aShukla, Dhananjay
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_9683527
700 _aVishvakarma, Naveen Kumar
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_9683528
700 _aNagaraju, Ganji Purnachandra
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_9683529
776 0 8 _iPrinted edition:
_z9783030727017
776 0 8 _iPrinted edition:
_z9783030727031
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-72702-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
_n0
998 _b04/2022
_dz
_ep
_zSI